SCHEMBL20299489

SCHEMBL20299489

C#Cc1ccc2c(c1)C(=O)CC2=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYMS P04818 2/20 0.36
GABRA1 P14867 3/20 0.35
GABRA5 P31644 3/20 0.35
GABRA2 P47869 3/20 0.35
GABRB2 P47870 3/20 0.35
GABRA3 P34903 2/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GRM5 P41594 4/20 0.33
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
CA14 Q9ULX7 2/20 0.32
CA4 P22748 1/20 0.32
LOXL2 Q9Y4K0 1/20 0.32
FFAR1 O14842 1/20 0.32
MAPT P10636 1/20 0.31
RECQL P46063 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29541396 0.83 GRM5 (0.46) GRM5
SCHEMBL30711519 0.79 CASP3 (0.43) GABRA1GABRA5GABRA2GABRA3GABRG2
SCHEMBL29141181 0.79 CASP3 (0.43) GABRA1GABRA5GABRA2GABRA3GABRG2
SCHEMBL16153831 0.76 GRM5 (0.38) GABRA1GABRA5GABRA2GABRB2GABRA3
SCHEMBL29203828 0.76 MAOA (0.44) TYMSCA12CA1CA2CA9
SCHEMBL3831665 0.76 CA12 (0.40) TYMSGABRA1GABRA5GABRA2GABRB2
SCHEMBL10190649 0.75 GRM5 (0.60) GRM5
SCHEMBL6979260 0.72 GRM5 (0.62) TYMSGRM5
SCHEMBL3621220 0.71 TYMS (0.39) TYMSGABRA1GABRA5GABRA2GABRB2
SCHEMBL571181 0.71 RAB9A (0.38) TYMSGRM5CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018114965-A1 CLPX INHIBITORY COMPOUNDS FOR THE TREATMENT OF MULTI RESISTANT STAPHYLOCOCCUS AUREUS VIRULENCE AND FOR THE TREATMENT OF LEUKEMIA Technische Universität München (DE) 2018-06-28 WO disclosed
WO-2018114965-A1 CLPX INHIBITORY COMPOUNDS FOR THE TREATMENT OF MULTI RESISTANT STAPHYLOCOCCUS AUREUS VIRULENCE AND FOR THE TREATMENT OF LEUKEMIA Technische Universität München (DE) 2018-06-28 WO disclosed